Ascentage Pharma Group Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Suzhou China (2009)

Organization Overview

First Clinical Trial
2016
NCT02935907
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Ascentage Pharma | Ascentage Pharma Group Inc. | Ascentage (Suzhou) Pharma Group Inc | Jiangsu Ascentage Pharma Co., Ltd. | yzhai@ascentage.com